Showing results (51-60 of 191) with videos related to

Sort By:
Pageof 20
Journal of Cancer Research and Clinical Oncology|May 29, 2020
Polypharmacy as a prognostic factor in older patients with advanced non-small-cell lung cancer treated with anti-PD-1/PD-L1 antibody-based immunotherapyTaiki Hakozaki, Yukio Hosomi, Akihiro Shimizu, et al.
Lung Cancer (Amsterdam, Netherlands)|June 14, 2011
Cisplatin and irinotecan combination chemotherapy for advanced thymic carcinoma: evaluation of efficacy and toxicityYusuke Okuma, Yukio Hosomi, Yusuke Takagi, et al.
General Thoracic and Cardiovascular Surgery|July 5, 2012
A case of successful preoperative chemotherapy with cisplatin and irinotecan followed by curative-intent surgery for locally advanced thymic carcinomaShigeki Suzuki, Hirotoshi Horio, Tai Hato, et al.
Future Oncology (London, England)|November 11, 2021
First-line osimertinib in EGFR mutation-positive non-small cell lung cancer patients with poor performance statusShigemasa Takamizawa, Yusuke Okuma, Yasuhiro Kato, et al.
International Journal of Clinical Oncology|December 10, 2015
Gemcitabine in patients previously treated with platinum-containing chemotherapy for refractory thymic carcinoma: radiographic assessment using the RECIST criteria and the ITMIG recommendationsYusuke Okuma, Yukio Hosomi, Kageaki Watanabe, et al.
Oncotargets and Therapy|May 7, 2021
Alectinib for Miliary Lung Metastasis in ALK-Positive Lung AdenocarcinomaHironori Satoh, Yusuke Okuma, Jumpei Kashima, et al.
Lung Cancer (Amsterdam, Netherlands)|March 21, 2014
The potency of curative-intent treatment for advanced thymic carcinomaYusuke Okuma, Hirotoshi Horio, Yukio Hosomi, et al.
Molecular and Clinical Oncology|May 19, 2017
Single-institutional experience of clinicopathological analysis and treatment for lung cancer patients with human immunodeficiency virus infectionSatoshi Takahashi, Yusuke Okuma, Kageaki Watanabe, et al.
Clinical Lung Cancer|June 4, 2018
Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non-Small-cell Lung CancerYusuke Okuma, Hiroshi Wakui, Hirofumi Utsumi, et al.
Onkologie|October 11, 2013
Concomitant chemoradiotherapy and antiretroviral therapy for HIV-infected patients with locoregionally advanced non-small cell lung cancer: benefit and tolerability of treatment in 2 casesYusuke Okuma, Naoki Yanagisawa, Yukio Hosomi, et al.
Pageof 20